- Home
- MRVI vs HRZN Comparison
MRVI vs HRZN Comparison
Compare MRVI & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- HRZN
- Stock Information
- Founded
- MRVI 2014
- HRZN 2008
- Country
- MRVI United States
- HRZN United States
- Employees
- MRVI N/A
- HRZN N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- HRZN Finance/Investors Services
- Sector
- MRVI Health Care
- HRZN Finance
- Exchange
- MRVI Nasdaq
- HRZN Nasdaq
- Market Cap
- MRVI 371.8M
- HRZN 295.3M
- IPO Year
- MRVI 2020
- HRZN 2010
- Fundamental
- Price
- MRVI $2.42
- HRZN $6.90
- Analyst Decision
- MRVI Hold
- HRZN Hold
- Analyst Count
- MRVI 10
- HRZN 4
- Target Price
- MRVI $5.84
- HRZN $7.81
- AVG Volume (30 Days)
- MRVI 1.4M
- HRZN 667.7K
- Earning Date
- MRVI 08-11-2025
- HRZN 08-07-2025
- Dividend Yield
- MRVI N/A
- HRZN 19.16%
- EPS Growth
- MRVI N/A
- HRZN N/A
- EPS
- MRVI N/A
- HRZN N/A
- Revenue
- MRVI $219,830,000.00
- HRZN $97,144,000.00
- Revenue This Year
- MRVI N/A
- HRZN $0.51
- Revenue Next Year
- MRVI $7.23
- HRZN $9.90
- P/E Ratio
- MRVI N/A
- HRZN N/A
- Revenue Growth
- MRVI N/A
- HRZN N/A
- 52 Week Low
- MRVI $1.67
- HRZN $6.77
- 52 Week High
- MRVI $9.60
- HRZN $11.15
- Technical
- Relative Strength Index (RSI)
- MRVI 49.60
- HRZN 30.61
- Support Level
- MRVI $2.28
- HRZN $6.86
- Resistance Level
- MRVI $2.47
- HRZN $6.96
- Average True Range (ATR)
- MRVI 0.14
- HRZN 0.09
- MACD
- MRVI -0.01
- HRZN -0.00
- Stochastic Oscillator
- MRVI 27.45
- HRZN 15.00
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.